The development of a stable sustained-release formulation of recombinant human nerve growth factor (rhNGF) for the treatment of neuronal diseases is described. The protein was encapsulated into poly(lactic-co-glycolic) acid (PLGA) microspheres using a spray freeze drying technique. Liquid nitrogen a
In vitro and in vivo release of nerve growth factor from biodegradable poly-lactic-co-glycolic-acid microspheres
✍ Scribed by Ralph de Boer; Andrew M. Knight; Robert J. Spinner; Martijn J. A. Malessy; Michael J. Yaszemski; Anthony J. Windebank
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 635 KB
- Volume
- 95A
- Category
- Article
- ISSN
- 1549-3296
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Regeneration of peripheral nerves after injury is suboptimal. We now report the long term delivery of nerve growth factor (NGF) by biodegradable poly‐lactic‐co‐glycolic acid (PLGA) microspheres in vitro and in vivo. Lactic to glycolic acid ratios of 50:50 and 85:15 were fabricated using the double emulsion solvent, evaporation technique. Three different inherent viscosities (0.1 dL g^−1^: 1A, 0.4 dL g^−1^: 4A, 0.7 dL g^−1^: 7A) were analyzed. In vitro, release of NGF for 23 days was measured. Electron microscopy demonstrated intact spheres for at least 7 days (50:50 1A), 14 days (50:50 4A), or 35 days (50:50 7A and 85:15 7A). In vitro release kinetics was characterized by burst release, followed by release of NGF at a rate of 0.6–1.6% a day. Release curves for 50:50 1A and 85:15 7A differed significantly from other compositions (p < 0.01). In vivo, release was characterized by a novel radionuclide tracking assay. Release rates varied from 0.9 to 2.2% per day with linear kinetics. All but the 85:15 type of spheres showed different release profiles in vivo compared to in vitro conditions. On the basis of the surface morphology and release profiles, we found microspheres fabricated from 50:50 4A PLGA to be best suited for the use in a rat sciatic nerve injury model. © 2010 Wiley Periodicals, Inc. J Biomed Mater Res Part A, 2010.
📜 SIMILAR VOLUMES
## Abstract This article describes the effects of six processing parameters on the release kinetics of a model drug Texas red dextran (TRD) from poly(propylene fumarate)/poly(lactic‐__co__‐glycolic acid) (PPF/PLGA) blend microspheres as well as the degradation of these microspheres. The microsphere
## Abstract A drug delivery vehicle was constructed that could be visualized noninvasively with MRI. The biodegradable polymer poly(DL‐lactic‐co‐glycolic acid) (PLGA) was used to fabricate microspheres containing vascular endothelial growth factor (VEGF) and the MRI contrast agent gadolinium diethy
## Abstract The immune response induced in mice by β‐galactosidase (β‐gal) adsorbed or encapsulated on poly(lactic acid) (PLA) and poly(lactic‐__co__‐glycolic acid) (PLGA) microspheres was investigated. The encapsulated protein elicited higher antibody response than the protein adsorbed on the micr
This study was designed to investigate the in vitro degradation of thin poly(DL-lactic-co-glycolic acid) (PLGA) films for applications in retinal pigment epithelium transplantation and guided tissue regeneration. PLGA films of copolymer ratios of 75:25 and 50:50 were manufactured with thickness leve